Background: Afatinib is an oral, irreversible ErbB family blocker indicated for first-line treatment of metastatic non-small cell lung cancer (NSCLC) in patients with non-resistant epidermal growth factor receptor (EGFR) mutations. Afatinib is also approved for the treatment of metastatic squamous...

Background: Head and neck cancer (HNC) survivors experience significant sequelae of treatment, including long-term physical side effects and ongoing cancer surveillance. Objectives: The aim of this study is to understand patients’ survivorship knowledge gaps and supportive care needs. Methods:...

I try to touch base with the clinic nurses each day before patients and physicians (in that order) start arriving and the usual busyness of the day takes over. A recent early morning conversation centered on one nurse’s frustration with the spouse of a man who had been treated in another city and...

Background: The palliative care needs of hospitalized patients often go unmet, resulting in unrelieved symptoms and a lack of understanding about advance care planning. Objectives: This article analyzes the 10-item Palliative Assessment Screening Tool (PAST) to determine if the PAST aids in the...